Background. Cardiovascular diseases (CVD) continue to be the leading cause of morbidity and mortality in Lithuania. The key modifiable factors identified for CVD prevention include lifestyle and behavior factors (e. g. diet, body weight, physical activity, cigarette smoking), and health risk factors (e. g. hypertension, hypercholesterolemia, etc.), also anxiety and depression are considered as potentially modifiable CVD risk factors as well. The aim of this study was to evaluate the association between psychosocial stress, manifested as anxiety and depression, and CVD.
INTRODUCTION
According to the World Health Organization coronary heart disease (CHD) and depression are the two most common diseases causing disability and worsening survival in the developed countries. It is predicted that prevalence of these diseases is going to increase and by 2020 depression will be the second leading cause of disability in developed countries, second only to heart disease (1). Epidemiological, clinical and pathogenetic issues of cardiovascular diseases (CVD) continue to be an important research topic as CVDs are the leading cause of death and disability worldwide; in Lithuania CVD accounts for as many as 56% of all death and significantly surpasses other death causes (2) .
It is well known that CVD risk is increased by certain risk factors: non-modifiable -sex, age, inheritance, and modifiable -arterial hypertension, dyslipidemia, smoking, overweight, and physical inactivity. Recently it has been shown that some psychological statuses, such as depression, anxiety or stress, are also potential risk factors for CVD (3).
Depression has an impact on the function of the hypothalamic -pituitary -adrenal axis: it decreases the secretion of cortisol and increases the secretion of the corticotrophin releasing factor, which enhances the release of glucocorticoids, being considered triggers of atherosclerosis, hypercholesterolemia, hypertension and hypertriglicerolemia (4) . Depression promotes activation of platelets, increases their adhesion and might induce development of acute coronary syndromes. Patients with depression have higher levels of C-reactive protein (CRP), which can activate the endothelium of coronary arteries and destabilize the atherosclerotic plaque (5) (6) .
Improved care of patients with CVD and depression and early risk evaluation in primary care centers would be useful in recommending adequate approach to the high cardiovascular risk patients.
The aim of this study was to evaluate the association between depression and anxiety and CVD in the Lithuanian population.
MATERIALS AND METHODS
In cooperation with primary care physicians 315 individuals (155 men and 162 women) over 40 years of age were selected for the investigation and were interviewed using a specially created validated questionnaire. The patients were interviewed using a specially created validated questionnaire comprising nutritional and lifestyle habits, family history, and health status. The answers of randomly selected 8% respondents were verified according to the medical documents at the local primary healthcare centers. All the cardiovascular diagnosis indicated by the patients were confirmed by medical documents. Depression and anxiety were assessed using the Hospital Anxiety and Depression (HAD) scale consisting of 14 questions: 7 concerning depression symptoms and 7 about anxiety; subscale score <8 indicated no depression or anxiety, [8] [9] [10] showed possible depression or anxiety, and >11 indicated probable presence of depression or anxiety.
Approval for the biomedical research was obtained from the Vilnius Regional Biomedical Research Ethics Committee (No. 158200-05-329-79) and an informed written consent was received from every participant of the study.
Participants for the study were gathered from the six ethnolinguistic groups representing Lithuania -Western, Eastern and Southern Aukštaiti-ja (Higher Lithuania) and Nothern, Western and Southern Žemaitija (Lower Lithuania). In addition, all of the participants were Lithuanians, i. e. at least three generations were living in the particular ethnolinguistic region.
Venous blood samples for biochemical testing were drawn after an overnight fasting at 7.30-11.00 a. m. at the local primary healthcare centers and immediately transported to the Centre of Laboratory Medicine, Vilnius University Hospital Santariškių Clinics. Biochemical blood parameters: total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), fasting glucose, C-reactive protein (CRP), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), their ratio (ApoB/ApoA1) and lipoprotein (a) were tested using standardized procedures.
A statistical analysis was performed using IBM SPSS 20 (Statistical Package for Social Sciences). During the description of investigated persons the interval variable averages and standard deviations were submitted as well as the lowest and highest means. Differences of interval variable averages were compared using the criteria of t-Student, one-factor dispersion analysis (ANOVA), for multiple comparisons applying post hoc Fisher's Least Significant Difference (LSD) criteria. For the assessment of the margin of efficiency the ratio of Cohen's d has been calculated. For the test of independence and genetic association analysis Pearson's chi-square (χ 2 ) statistics has been applied. In order to evaluate the influence of the independent factors on the dependent variable a logistic regression analysis has been applied. A significance level of 0.05 has been chosen. 
RESULTS
General characteristics and biochemical parameters of the studied individuals are summarized in Table 1 . The studied population was comprised of 155 men (48.9%) and 162 women (51.1%). The comparison of clinical characteristics and biochemical blood parameters between men and women groups is presented in Table 2 .
In the studied population clinical symptoms of anxiety (HAD scale Anxiety score >8) were present in 103 (32.5%) individuals, meanwhile clinical symptoms of depression (HAD scale Depression score >8) were present in 43 (13.6%). Mean values of HAD scale Anxiety and Depression scores are given in Table 3 . The distribution of severity of depression and anxiety symptoms in the studied population is shown in Fig. 1 .
The analysis of the relation between symptoms of anxiety and depression and biochemical blood parameters showed only a moderate statistically significant relation between the anxiety and depression scores (r = 0.516, p < 0.01). However, no significant relation between HAD scores and biochemical blood parameters was found. The analysis of the mental status in men and women groups showed that the median of depression symptoms was significantly higher in the women group in comparison to the men group (p < 0.001) ( Table 4) . Clinical symptoms of anxiety (HAD Anxiety score >8) were present in 51 (32.9%) male subjects and 52 (32.1%) female subjects (p = 0.905). Meanwhile, clinical symptoms of depression (HAD Depression score >8) were present in 12 (7.7%) men in comparison to 31 (19.1%) women (p = 0.003). The distribution of severity of symptoms of anxiety and depression in men and women groups are shown in Figs. 2 and 3.
23.3% (n = 74) of the studied population comprised patients with CVD, among them 17.6% (n = 13) men and 82.4 (n = 61) women. The prevalence of CVD was significantly higher among women compared to men (37.7% vs 8.4%, p < 0.001). The clinical characteristics and bio- chemical parameters between the groups of patients with and without CVD were not significantly different (Table 5 ). The comparison of the mental status between the groups of individuals with and without CVD showed that the median HAD Anxiety score was statistically higher in patients with CVD vs individuals without CVD (p = 0.013). Likewise, the median HAD Depression score was also statistically higher in patients with CVD vs individuals without CVD (p < 0.0001) ( Table 6 ).
Clinical symptoms of anxiety and depression were significantly more prevalent in individuals with CVD in comparison to those without CVD (Table 7 ). The distribution of the severity of anxiety and depression symptoms in individuals with and without CVD is shown in Figs. 4 and 5.
Analyzing the dependence of cardiovascular morbidity on depression and anxiety symptoms and biochemical blood parameters, a multivariate stepwise backward conditional logistic regression analysis was performed. In the initial model the dependent variable was cardiovascular morbidity and included independent variables were age, sex, BMI, glucose, total cholesterol, HDL-C, LDL-C, triglycerides, CRB, apoA1 and apoB levels, as well as HAD Depression and Anxiety scores. In the studied population CVD morbidity was dependent on sex, LDL cholesterol, apolipoprotein B and depression symptoms. Women had an odds ratio of CVD 7.14 higher than men. The increase in apolipoprotein B concentration by 1 g/l increased odds ratio of CVD 12.03 fold, meanwhile the increase of depression score by 1 point increased CVD risk 1.16 fold.
Analyzing the dependence of cardiovascular morbidity on depression and anxiety symptoms a multivariate logistic regression analysis was performed. In the initial model dependent variable was cardiovascular morbidity and independent variables were HAD scale Depression and Anxiety scores. The final model had 76.3 correct classification; the Cox-Snell pseudotermination coefficient was r CS 2 = 0.062 and the Nagelkerke pseudotermination coefficient was r CS 2 = 0.093. We have found a statistically significant relation between CVD morbidity and depression symptoms: the increase in depression symptoms by 1 point increased the possibility of the hazzard ratio by 1.18 times (β = 0.17, OR = 1.18 (1.07-1.31), p = 0.001). Meanwhile, a statistically important correlation between anxiety and CVD was not found.
DISCUSSION
Depression and coronary heart diseases are commonly presented together. Depression is more prevalent among patients with CHD in comparison to general population; more than 20% of the patients hospitalized due to myocardial infarction meet the criteria of the major depression disorder (7) . Multiple research results support the relation between depression and increased risk of CHD and CVD mortality, however, the relationship could be bidirectional. Results of the meta-analysis confirm the role of depression in the development of CHD reporting effect sizes between 1.5 and 2.7 (9-10). The meta-analysis of the systemic review and 28 prospective studies confirmed the association between depression and stroke. These studies were performed in European and North American medicine centers and found that depression was significantly related to increased risk of stroke (HR 1.45, 95% CI [1.29-1.63]) (11) . In our study we have found that the increase of HAD Depression score by 1 point increases the odds ratio by 1.16 fold.
The atherosclerotic process starts in early life and is influenced by various potentially modifiable risk factors, lifestyle and environment. In a prospective population study involving 37,291 Norwegians it was found that depression and anxiety were significantly related to the risk of developing type 2 diabetes in 10 years (OR 1.8, 95% CI [1.3-2.5]) (12) . In 2003 Danner et al. reported an association between depression and increased CRP level (13) . However, in our study we did not find any significant correlation between depression or anxiety and the investigated biochemical blood parameters.
CONCLUSIONS
We did not find any significant correlation between the investigated biochemical blood parameters and HAD score, but there was a significant association between the depression HAD score and cardiovascular morbidity.
